SI1817326T1 - Industrijski postopek za pripravo gama-laktona 17-hidroksi-6-beta, 7-beta, 15-beta, 16-beta-bismetilen-3-okso 17-alfa pregn-4-en-21- karboksilne kisline in kljuäśni intermediati za ta postopek - Google Patents

Industrijski postopek za pripravo gama-laktona 17-hidroksi-6-beta, 7-beta, 15-beta, 16-beta-bismetilen-3-okso 17-alfa pregn-4-en-21- karboksilne kisline in kljuäśni intermediati za ta postopek

Info

Publication number
SI1817326T1
SI1817326T1 SI200531046T SI200531046T SI1817326T1 SI 1817326 T1 SI1817326 T1 SI 1817326T1 SI 200531046 T SI200531046 T SI 200531046T SI 200531046 T SI200531046 T SI 200531046T SI 1817326 T1 SI1817326 T1 SI 1817326T1
Authority
SI
Slovenia
Prior art keywords
beta
bismethylene
pregn
lactone
ene
Prior art date
Application number
SI200531046T
Other languages
English (en)
Inventor
Bela Soros
Judit Horvath
Gyorgy Galik
Jozsef Bodi
Zoltan Tuba
Sandor Maho
Gabor Balogh
Antal Aranyi
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of SI1817326T1 publication Critical patent/SI1817326T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0083 membered carbocyclic rings in position 15/16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Lubricants (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Pyrane Compounds (AREA)
SI200531046T 2004-11-30 2005-10-11 Industrijski postopek za pripravo gama-laktona 17-hidroksi-6-beta, 7-beta, 15-beta, 16-beta-bismetilen-3-okso 17-alfa pregn-4-en-21- karboksilne kisline in kljuäśni intermediati za ta postopek SI1817326T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0402465A HUP0402465A2 (en) 2004-11-30 2004-11-30 Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
EP05797354A EP1817326B1 (en) 2004-11-30 2005-10-11 Industrial process for the preperation of 17-hydroxy -6 beta, 7-beta, 15-beta, 16-beta-bismethylene-3-oxo 17-alpha pregn-4-ene-21-carboxylic acid gamma-lactone and key intermediates for this process
PCT/HU2005/000110 WO2006059167A1 (en) 2004-11-30 2005-10-11 INDUSTRIAL PROCESS FOR THE PREPARATION OF 17-HYDROXY-6β,7β;15β,16β-BISMETHYLENE-3-OXO-17α-PREGN-4-ENE-21-CARBOXYLIC ACID Ϝ-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS

Publications (1)

Publication Number Publication Date
SI1817326T1 true SI1817326T1 (sl) 2010-08-31

Family

ID=89985651

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531046T SI1817326T1 (sl) 2004-11-30 2005-10-11 Industrijski postopek za pripravo gama-laktona 17-hidroksi-6-beta, 7-beta, 15-beta, 16-beta-bismetilen-3-okso 17-alfa pregn-4-en-21- karboksilne kisline in kljuäśni intermediati za ta postopek

Country Status (17)

Country Link
US (1) US8309712B2 (sl)
EP (1) EP1817326B1 (sl)
JP (1) JP4971179B2 (sl)
CN (1) CN101061133B (sl)
AT (1) ATE468349T1 (sl)
AU (1) AU2005311059B2 (sl)
CA (1) CA2585802C (sl)
CY (1) CY1110098T1 (sl)
DE (1) DE602005021395D1 (sl)
DK (1) DK1817326T3 (sl)
ES (1) ES2345560T3 (sl)
HK (1) HK1107354A1 (sl)
HU (1) HUP0402465A2 (sl)
PL (1) PL1817326T3 (sl)
PT (1) PT1817326E (sl)
SI (1) SI1817326T1 (sl)
WO (1) WO2006059167A1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ES2355586T3 (es) 2007-07-26 2011-03-29 Newchem S.P.A. Procedimiento de preparación de drospirenona.
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
DE102009038972A1 (de) * 2009-08-23 2011-06-30 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG, 14167 Verfahren zur Herstellung von Drospirenon aus 6,7,15,16-Dimethylenandrost-4-en-3,17-dion
DE102009031907B4 (de) * 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus Androstendion
DE102009031908B4 (de) * 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus 15-Hydroxyandrostendion
DE102009031909B4 (de) * 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus Prasteron
CN109232700B (zh) * 2018-09-17 2020-06-26 宁波三生生物科技有限公司 一种烯丙孕素的高效合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540896A (de) 1966-04-02 1973-10-15 Schering Ag Verfahren zur Herstellung von 15,16B-Methylensteroiden
CH510002A (de) 1968-04-22 1971-07-15 Hoffmann La Roche Verfahren zur Herstellung neuer Pregnene
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2746298A1 (de) * 1977-10-13 1979-04-19 Schering Ag 4-androsten-3,17-dion-derivate, ihre herstellung und verwendung
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
DE3265852D1 (en) 1981-09-21 1985-10-03 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens

Also Published As

Publication number Publication date
PL1817326T3 (pl) 2010-10-29
CA2585802A1 (en) 2006-06-08
ATE468349T1 (de) 2010-06-15
DE602005021395D1 (de) 2010-07-01
US20080200668A1 (en) 2008-08-21
HK1107354A1 (en) 2008-04-03
JP4971179B2 (ja) 2012-07-11
JP2008521875A (ja) 2008-06-26
CN101061133B (zh) 2011-01-26
HUP0402465A2 (en) 2006-07-28
DK1817326T3 (da) 2010-08-30
EP1817326B1 (en) 2010-05-19
PT1817326E (pt) 2010-06-25
CY1110098T1 (el) 2015-01-14
AU2005311059A1 (en) 2006-06-08
US8309712B2 (en) 2012-11-13
CN101061133A (zh) 2007-10-24
EP1817326A1 (en) 2007-08-15
AU2005311059B2 (en) 2011-01-06
WO2006059167A1 (en) 2006-06-08
HU0402465D0 (en) 2005-01-28
CA2585802C (en) 2009-09-08
ES2345560T3 (es) 2010-09-27

Similar Documents

Publication Publication Date Title
SI1817326T1 (sl) Industrijski postopek za pripravo gama-laktona 17-hidroksi-6-beta, 7-beta, 15-beta, 16-beta-bismetilen-3-okso 17-alfa pregn-4-en-21- karboksilne kisline in kljuäśni intermediati za ta postopek
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
GEP20146055B (en) Inhibitors of renal outer medullary potassium channel
WO2009111653A3 (en) Antiviral therapeutic agents
MX348481B (es) Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas.
MX2009004746A (es) Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
WO2008115281A3 (en) Compounds for treating viral infections
MX2012000565A (es) Derivados de triterpeno tipo lupeol como antivirales.
IN2012DN00971A (sl)
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MX2008011576A (es) Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
TW200613317A (en) Steroid prodrugs with androgenic action
WO2007061878A3 (en) 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
WO2007059356A3 (en) Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
ZA200700171B (en) Substituted hydroxyacetophenon derivatives
WO2010131118A3 (en) Polymorphs of etravirine and processes for preparation thereof
WO2009110938A3 (en) Novel macrocyclic polyene lactams
MX2010003056A (es) Polimorfos de valomaciclovir.
WO2004092736A3 (en) Derivatives of azithromycin
TW200700389A (en) 5h-benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents
WO2008097341A3 (en) Antiviral compounds and use thereof